Mycobacterium vaccae in the treatment of uveitis

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/04 (2006.01) A61K 38/16 (2006.01)

Patent

CA 2095854

Use of antigenic or immunoregulatory material derived from Mycobacterium vaccae in the manufacture of a therapeutic agent for treatment of uveitis. The M. vaccae is suitably in the form of dead cells, preferably billed by autoclaving. The therapeutic agent preferably contains, per dose, antigenic or immunoregulatory material from 10 7 to 10 10 M. vaccae microorganisms.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Mycobacterium vaccae in the treatment of uveitis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mycobacterium vaccae in the treatment of uveitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mycobacterium vaccae in the treatment of uveitis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1365584

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.